Jing Mi
Impact in
- Cancer Research top 10%
- Molecular Biology top 10%
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- RNA and protein synthesis mechanisms
- Angiogenesis and VEGF in Cancer
- DNA and Nucleic Acid Chemistry
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
- Angiogenesis and VEGF in Cancer 5
- Physiology 11
- Alzheimer's disease research and treatments 9
- Co-authors
- Bryan M. Clary (13 shared papers)Bruce A. Sullenger (8 shared papers)Yingmiao Liu (5 shared papers)Zahid N. Rabbani (4 shared papers)Mark W. Dewhirst (5 shared papers)Xiuwu Zhang (6 shared papers)Zhongguang Yang (2 shared papers)Johannes Urban (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (4 papers)Journal of Surgical Research (3 papers)Medicinal Chemistry Research (3 papers)BMC Cardiovascular Disorders (3 papers)
- Partner nations
- ChinaUnited StatesLaos
In The Last Decade
Jing Mi
63 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 202
- Molecular Biology 883
- Immunology 146
- Immunology and Allergy 39
- Pharmacology 104
Countries citing papers authored by Jing Mi
This map shows the geographic impact of Jing Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Mi more than expected).
Fields of papers citing papers by Jing Mi
This network shows the impact of papers produced by Jing Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Mi. The network helps show where Jing Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 213 | |
| 2 | 2020 | 116 | |
| 3 | 2007 | 78 | |
| 4 | 2010 | 73 | |
| 5 | 2007 | 69 | |
| 6 | 2008 | 69 | |
| 7 | 2001 | 63 | |
| 8 | 2005 | 60 | |
| 9 | 2016 | 50 | |
| 10 | 2004 | 47 | |
| 11 | 2008 | 41 | |
| 12 | 2005 | 38 | |
| 13 | 2015 | 27 | |
| 14 | 2023 | 25 | |
| 15 | 2023 | 25 | |
| 16 | 2018 | 25 | |
| 17 | 2019 | 24 | |
| 18 | 2021 | 24 | |
| 19 | 2018 | 23 | |
| 20 | 2020 | 23 |
About Jing Mi
Jing Mi is a scholar working on Molecular Biology, Physiology, Cancer Research, Pharmacology and Biomedical Engineering, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (10 papers), Alzheimer's disease research and treatments (9 papers), RNA Interference and Gene Delivery (6 papers), Air Quality and Health Impacts (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Cancer Research (202 citations), Molecular Biology (883 citations), Immunology (146 citations), Immunology and Allergy (39 citations) and Pharmacology (104 citations). Jing Mi has collaborated with scholars based in China, United States and Laos. Frequent co-authors include Bryan M. Clary, Bruce A. Sullenger, Yingmiao Liu, Zahid N. Rabbani, Mark W. Dewhirst, Xiuwu Zhang, Zhongguang Yang, Johannes Urban, Rebekah R. White and Shiva Sarraf‐Yazdi. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Enzyme Inhibition and Medicinal Chemistry, Journal of Surgical Research, Medicinal Chemistry Research and BMC Cardiovascular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.